In PD, astrocytes derived from LRRK2 or GBA mutation carriers demonstrate defective lysosomal activity and decrease neuroprotective capacity, amplifying α-synuclein toxicity [62,63]. The gene discussed is LRRK2; the disease is Parkinson disease.